Summary measure for CD38
Before constructing a prognostic model with CD38 as a predictor, the correlation between the scores across the different histological grades was assessed. The correlation between the average CD38 expression between normal, PIN, and cancer cores was computed using Spearman's rank correlation coefficient. The correlations between the 3 regions were fairly low (between 0.20-0.30) indicating some biological variation across the different core sample types within an individual. In general the cancer cores expressed lower CD38 levels compared to the PIN and normal regions ( Figure 5C ). Cox proportional-hazards models were used to determine the prognostic ability of CD38 as a predictor of biochemical recurrence. A statistically significant association between overall mean (low) expression of CD38 and time to biochemical recurrence was observed (p=0.025). All analyses were performed in SAS V9.4 (SAS Institute, Cary, NC) and SPSS V22 (IBM Corp., Armonk, NY). P-values <0.05 were considered statistically significant.
Antibodies used
FACS and flow cytometry: CD45-APC-eFluor® 780 (47-0459-41, eBiosciences), EpCAM-APC (324207, BioLegend), CD49f-PEcy7 (313621, BioLegend), CD38-PE (303505, BioLegend) and CD26-FITC (302705, BioLegend), Keratin 18-FITC antibody (ab72813, Abcam) Keratin 5-FITC (FCMAB291F, Millipore).
Immunohistochemistry: CD38 (LS-B8131, Lifespan Biosciences; sc-374650, Santa Cruz), CD45 (M0701, Dako), CD4 (MS-1528, Thermo Scientific), CD8 (M7103, Dako), CD11c (ab52632, Abcam), CD68 (M0876, Dako), CD20 (M0755, Dako), CD26 (LS-A9024, Lifespan Biosciences), Keratin 5 (905501, Biolegend), Keratin 8 (904801, BioLegend), p63 (sc-8431, Santa Cruz), AR (M3562, Dako), PSA (A0562, Dako), FKBP5 (ab126715, Abcam), MSMB (ab133296, Abcam), PSCA (LS-B3332, Lifespan Biosciences), NF-kB p65 phosphorylated S536 (ab86299, Abcam), TNF alpha (60291-1-Ig, Proteintech), Myc (ab32072, Abcam), phospho-AKT (3787, Cell Signaling), Ki67 (M7240, Dako), Nkx3-1 (0314, Athena Environmental Sciences).
Immunoblot: p63 (sc-8431, Santa Cruz), CD38 (sc-374650, Santa Cruz), K14 (905301, BioLegend), Histone H3 (9715, Cell Signaling), AR (sc-816, Santa Cruz), NF-kB p65 (ab31481, Abcam), NF-kB p65 phosphorylated S536 (ab86299, Abcam), BCL2 (M0887, Dako). 
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** p = 0.0045 n.s. n.s. Tables   Table S1. CD38-lo luminal gene signature and RPKM values, related to Figure 3 . Table  S1A indicates genes listed by official gene symbol or ID and the average fold change for CD38-lo luminal cells compared to CD38+ luminal (middle) or basal cells (right) from three distinct individuals. The signature is restricted to genes with expression in CD38-lo luminal cells that is 2-fold greater than CD38+ luminal and 1.5-fold greater than basal cells. Table S4 . Association between low protein expression of CD38 and biochemical recurrence, related to Figure 5 . Cox proportional-hazards model was used to calculate the association between low expression of CD38 and time to biochemical recurrence. Pvalues <0.05 were considered statistically significant. 
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